Transforming the Care of Patients With Thyroid Cancer
There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.
Diagnosis & Disease Information
VP Biden Talks About the Role of CancerLinQ at ASCO 2016
At the 2016 ASCO meeting, Vice President Joe Biden spoke about his vision for comprehensive data-sharing as part of the Cancer MoonShot initiative.
Survey Highlights Barriers to Global Data Sharing
Funding, informatics system, clinical data capture, and European data protection legislation were considered the greatest barriers to effective data sharing.
Immunotherapy Combination is Effective in Colorectal Cancer
Cbimetinib and atezolizumab was well tolerated and demonstrated encouraging clinical activity in microsatellite stable colorectal cancer (CRC).
Monoclonal Antibody Shows Promise in Aggressive R/R Adult T-cell Leukemia/Lymphoma
Mogamulizumab induced an encouraging response rate in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Double Autologous HCT Improves Outcomes in High-risk Pediatric Neuroblastoma
Adding a second autologous hematopoietic cell transplantation (HCT) to standard therapy improves outcomes for pediatric patients with high-risk neuroblastoma.
Trastuzumab Biosimilar Comparable the Monoclonal Antibody for Advanced HER2+ Breast Cancer
MYL-1401O is comparable in efficacy and safety to the anti-HER2 monoclonal antibody trastuzumab as frontline therapy in breast cancer.
More Data Needed on Cancer Treatment Costs
More transparency regarding the costs of various treatment regimens in real time is needed to “choose wisely” for patients, providers, and payers.
Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
Physical exercise may have a direct effect on cancer that is as effective as drugs for treating patients with prostate cancer, even for those with advanced stages of the disease.
Web Application Improves Follow-up in Patients With Advanced Lung Cancer
A Web application called Moovcare that guides follow-up improved survival for patients with advanced lung cancer after receiving initial therapy.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...